comparemela.com

Latest Breaking News On - Dice therapeutics - Page 5 : comparemela.com

Lilly expands radiopharmaceutical portfolio with $1 4B Point Biopharma deal

The transaction has been approved by the board of directors at both companies and Lilly said it expects the deal to close near the end of the year.

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

DICE Therapeutics, Inc (NASDAQ:DICE) Receives $62 40 Consensus Target Price from Brokerages

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Free Report) has been assigned an average recommendation of “Hold” from the thirteen brokerages that are presently covering the firm, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target among […]

7 A-Rated Biotech Stocks for Your August Buy List

Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

Short Interest in DICE Therapeutics, Inc (NASDAQ:DICE) Declines By 10 7%

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Free Report) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 4,360,000 shares, a decrease of 10.7% from the July 15th total of 4,880,000 shares. Approximately 10.4% of the company’s stock are short sold. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.